Medication Management of Antipsychotic-Induced Weight Gain in Children and Teens

Dr. Feder: Of approximately one million US children and adolescents, roughly 1% are prescribed second-generation antipsychotics. These medications routinely lead to weight gain in kids and teens even beyond the 7% that the FDA’s calls it’s ‘level of concern’. The worst offenders are olanzapine, quetiapine, and risperidone. Lurasidone and ziprasidone are of less concern, and of course there is every bit of in between including aripiprazole. In this episode, we’ll discuss the efficacy and safety of using off-label medications, such as metformin, to manage metabolic side effects of second-generation antipsychotics. 

Welcome to The Carlat Psychiatry Podcast.

This is another episode from the child psychiatry team. 

I’m Dr. Josh Feder, The Editor-in-Chief of The Carlat Child Psychiatry Report and co-author of The Child Medication Fact Book for Psychiatric Practice and the brand-new book, Prescribing Psychotropics.

Mara: And I’m Mara Goverman, a Licensed Clinical Social Worker in Southern California with a private practice. 

Listen here: https://www.thecarlatreport.com/podcast/medication-management-of-antipsychotic-induced-weight-gain-in-children-and-teens/

Author
Joshua Feder, M.D. Dr. Feder's Blog

You Might Also Enjoy...

Autism and Medication: Dr Feder's New Algorithm!

This is part 2 because there is a new Child Medication Fact Book for Psychiatric Practice, Second Edition that just came out. Dr. Feder is here to tell us the purpose of the book and to walk us through his new algorithm for supporting autistic kids.

Improving Sleep in Children and Adolescents

We are in the midst of "The Great Sleep Recession." How can we enhance the quality of sleep in children and adolescents? Mara and I dive into sleep on this episode of The Carlat Psychiatry Podcast.